Working With Liver Patients: What Actually Changes in the Gym

Most physical therapists see a hepatitis diagnosis on intake and immediately think "reduce everything." That instinct is half right and dangerously incomplete. I learned the hard way when a 41-year-old with chronic hepatitis C came in six months post-diagnosis, completely deconditioned after being told to avoid all exertion. His VO2 max had dropped to 22. He could barely walk to the end of the hallway without stopping. The "just rest" advice had made him worse. The core problem isn't the virus itself. It's the systemic fatigue, the possible splenomegaly, and the altered drug metabolism that changes how patients respond to standard exercise prescriptions. Here's what I actually do.

Setting Up a Hep In Physical Therapy Program

Start with labs, not fitness tests. You need to know the patient's platelet count, INR, albumin level, and whether they have ascites or varices. If platelets are below 50,000, you're looking at bleeding risk with any resistance work. If there's splenomegaly — enlarged spleen — you absolutely do not do contact sports, heavy core compression, or anything that risks abdominal trauma. I had a cirrhotic patient who developed a splenic rupture during a supervised kettlebell session because nobody checked the spleen size on exam before starting. That's the edge case that keeps you up at night. For cardiac output and exercise tolerance, use the 6-minute walk test as your baseline, not a VO2 test. It's safer, it doesn't stress the liver, and it gives you a real-world functional number. Track resting heart rate and blood pressure before every session for the first three visits. Some hepatitis patients have autonomic dysfunction from chronic inflammation, and their heart rate response to exercise is blunt or delayed. You'll miss that if you just jump into programming. Exercise intensity for compensated hepatitis patients typically sits at 40 to 60 percent of heart rate reserve, or a Borg RPE of 3 to 5 out of 10. That's light by most standards, and it should stay there for the first four to six weeks. The fatigue in liver disease isn't psychological — it's metabolic. The liver can't clear lactate as efficiently, ammonia accumulation affects central nervous system function, and patients crash hard and fast. Pushing through that fatigue is how you set back recovery. For resistance training, start with bodyweight only. Sit-to-stand from a chair, wall push-ups, seated band rows with very light resistance. If platelets are above 80,000 and there's no splenomegaly, you can progress to machines before free weights. Machines are safer because the path of motion is fixed — less risk of dropping a weight on the abdomen, less core destabilization. Free weights come later, and only after you've seen how the patient tolerates the machine work for at least two weeks. Cardio should be predominantly low-impact cycling or recumbent walking. The recumbent bike matters because it takes compressive load off the abdomen. Upright cycling can aggravate ascites or put pressure on an enlarged liver. Treadmill walking is fine if gait is stable, but many hepatitis patients have peripheral edema that makes walking uncomfortable and alters their biomechanics. I track step count and perceived exertion together — a patient might feel fine at 3,000 steps but their RPE should match. If RPE is 6 at 3,000 steps, they're overreaching. Breathing and core work get special attention. Diaphragmatic breathing is useful both as a warm-up and as a fatigue management tool. But traditional core exercises — crunches, planks, sit-ups — are generally contraindicated in the early phases because they increase intra-abdominal pressure. For patients with portal hypertension, that pressure spike can be dangerous. I substitute with bird-dogs and dead bugs on the floor, which engage the core without the same pressure buildup. The counter-intuitive part that beginners miss: progressive resistance training in hepatitis patients actually improves liver function markers over time. I've seen ALT and AST levels drop after 12 weeks of supervised, appropriately dosed strength work. The mechanism isn't direct liver repair — it's improved insulin sensitivity, reduced systemic inflammation, and better body composition. But the dosage has to be right. Overdo it and you worsen fatigue and potentially trigger bleeding. Underdo it and you gain nothing. The sweet spot is 2 to 3 days per week, 1 to 2 sets of 10 to 12 repetitions at moderate resistance, progressing no faster than 5 percent per week. What this approach doesn't fix: acute hepatitis. During the active inflammatory phase, when bilirubin is elevated and the patient is jaundiced, exercise should be minimal. Rest is the treatment then, not gradual return. The protocols I'm describing are for chronic or convalescent hepatitis, not the acute phase. I once tried to ramp a patient back into exercise during an acute flare and watched their bilirubin climb and their fatigue worsen for two weeks. We went back to gentle walking only and it resolved. The biggest limitation of any structured program like this is patient adherence driven by fatigue. Hepatitis fatigue doesn't respond to caffeine or willpower the way ordinary tiredness does. A patient who exercises well on Monday might be unable to stand upright on Wednesday for no clear reason. The workaround is flexible scheduling — offer make-up sessions within the same week, don't punish missed days with doubled work, and use home exercise programs as the primary vehicle with clinic visits as supervision checkpoints. Most of the actual work happens at home, and home adherence correlates more with program simplicity than with patient motivation. Track these three things at every visit: resting heart rate, sleep quality the night before, and appetite. All three are indirect markers of systemic inflammation and liver function. If all three deteriorate over two weeks without a change in exercise load, you're either underestimating the disease severity or the patient has a comorbid condition you haven't addressed. Drop back to baseline and reassess rather than pushing through.

When to Refer and When to Hold

Send to hepatology if you see jaundice, unexplained weight loss, bruising that doesn't resolve, or confusion about timing. These aren't exercise problems — they're disease progression signals. Your role ends at the boundary between rehab and medical management. Staying in your lane protects the patient and protects your practice. For patients who are post-liver transplant, the protocol changes substantially. Immunosuppression alters infection risk, bone density is lower, and medication timing affects exercise windows. That's a different conversation entirely, and one I defer to the transplant rehab specialists. The practical takeaway is this: hepatitis doesn't mean exercise is off the table, but it does mean the standard templates don't apply. You build from labs, you respect the fatigue curve, and you progress slower than you think you should. The patients who come back strongest are the ones who get appropriate, consistent movement — not the ones who sit out completely.